Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment.

Massey AE, Sikander M, Chauhan N, Kumari S, Setua S, Shetty AB, Mandil H, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Hafeez BB, Chauhan SC.

Nanomedicine. 2019 Aug;20:102027. doi: 10.1016/j.nano.2019.102027. Epub 2019 Jun 4.

PMID:
31170509
2.

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer.

Sikander M, Malik S, Chauhan N, Khan P, Kumari S, Kashyap VK, Khan S, Ganju A, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC.

Cancers (Basel). 2019 Mar 14;11(3). pii: E364. doi: 10.3390/cancers11030364.

3.

Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.

Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Chauhan SC, Jaggi M.

Mol Cancer Ther. 2017 Oct;16(10):2267-2280. doi: 10.1158/1535-7163.MCT-17-0157. Epub 2017 Jun 14.

4.

Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.

Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M.

Sci Rep. 2016 Nov 8;6:36594. doi: 10.1038/srep36594.

5.

Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy.

Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, Jaggi M, Chauhan SC.

J Gastrointest Surg. 2017 Jan;21(1):94-105. doi: 10.1007/s11605-016-3222-z. Epub 2016 Aug 9.

6.

Curcumin Nanoformulation for Cervical Cancer Treatment.

Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, Kumari S, Sikander M, Khan S, Zafar N, Jaggi M, Chauhan SC.

Sci Rep. 2016 Feb 3;6:20051. doi: 10.1038/srep20051.

7.

Cyst or tumor in the buccomaxillary region: Review of literature and a case report.

Raheel SA, Kujan OB, Dwedary HM, Sikander MH, Mankar S, Amrin MN.

J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S752-5. doi: 10.4103/0975-7406.163540.

8.

MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.

Khan S, Ebeling MC, Zaman MS, Sikander M, Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D, Thompson PA, Jaggi M, Chauhan SC.

Oncotarget. 2014 Sep 15;5(17):7599-609.

Supplemental Content

Loading ...
Support Center